Biotech stocks took another dive Monday, and some CNBC "Fast Money" traders believe the struggles could extend to other high-growth names.
The iShares Nasdaq Biotechnology ETF fell more than 6 percent on the day amid renewed concerns about government action to rein in drug prices. The fund went further into bear market territory, or 20 percent lower than its 52-week high, on a day when major U.S. averages all lost about 2 percent or more.
While biotech stocks sometimes take big hits as market enthusiasm wanes, high-flying technology names could come next, some traders said. Facebook, Amazon, Netflix and Google have all easily beaten the S&P 500 this year, but Google may prove the safest pick if volatility continues, said trader Tim Seymour.
"I think Google is defensive," said Seymour, who owns the stock, which fell nearly 3 percent Monday.